This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Specific Pharma A/s
Specific Pharma A/S, headquartered in Denmark (DK), is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of innovative drug delivery systems. Founded in [year], the company has established a strong presence in major operational regions across Europe and beyond, focusing on enhancing patient outcomes through advanced pharmaceutical solutions. With a commitment to quality and innovation, Specific Pharma A/S offers a range of unique products and services, including tailored formulations and cutting-edge delivery technologies. The company has achieved notable milestones, positioning itself as a trusted partner in the healthcare sector. Recognised for its expertise and dedication, Specific Pharma A/S continues to lead the way in providing effective and reliable pharmaceutical solutions, making significant contributions to the industry.
DitchCarbon Score
How does Specific Pharma A/s's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Specific Pharma A/s's score of 61 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Specific Pharma A/s, headquartered in Denmark (DK), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of PHOENIX Pharmahandel SE, which may influence its climate commitments and reporting practices. While Specific Pharma A/s has not established its own reduction targets or climate pledges, it is important to note that it inherits data and initiatives from its parent company. The emissions data and performance metrics are cascaded from PHOENIX Pharmahandel GmbH & Co KG at a cascade level of 3, and from PHOENIX Pharmahandel SE at a cascade level of 4. This relationship may provide a framework for future climate commitments and emissions reporting. As of now, Specific Pharma A/s has not outlined any specific initiatives or targets related to the Science Based Targets initiative (SBTi) or other industry-standard climate frameworks. The absence of reported emissions data suggests that the company may still be in the early stages of developing its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 20,501,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 47,693,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 140,907,000 | 000,000,000 | 00,000,000 | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Specific Pharma A/s is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
